ENHANCEMENT OF LORNOXICAM SOLUBILITY BY INCLUSION COMPLEXATION WITH CYCLODEXTRIN: PREPARATION AND CHARACTERIZATION
DOI:
https://doi.org/10.22159/ijpps.2017v9i1.14848Keywords:
Lornoxicam, Cyclodextrin, Lyophilization, Physical mixing, Inclusion complexAbstract
Objective: Lornoxicam is a potent anti-inflammatory drug which has analgesic and antipyretic properties. It is water-insoluble powder. The inclusion complexes of lornoxicam (LOR) with β-cyclodextrin (βCD) and 2-hydroxypropyl-β-cyclodextrin (HPCD) were prepared and characterised in order to improve the solubility of the drug and enhance its bioavailability.
Methods: Complexes were prepared by physical mixing and freeze-drying in three different drug/polymer ratios (1:1, 1:2 and 3:2). The solid complexes were characterised through differential scanning calorimetry (DSC), scanning electron microscopy (SEM), X-ray diffraction, nuclear magnetic resonance (NMR) spectroscopy, and Fourier transformed infrared (FTIR) spectroscopy.
Results: The data showed that LOR may be complexed with cyclodextrin (CD) forming soluble complexes. The lyophilized 1:2 LOR/HPCD complex is the most soluble.
Conclusion: Solubility increases with lyophilization than with physical mixing and by the use of HPCD than βCD in complexation.
Downloads
References
Ingle P, Patil PH, Lathi V. Study of rational prescribing and dispensing of prescriptions with non-steroidal anti-inflammatory drugs in the orthopedic outpatient department. Asian J Pharm Clin Res 2015;8:278-81.
Banerjee R, Chakraborty H, Sarkar M. Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam. Spectrochim Acta Part A 2003;59:1213-22.
Sarangi MK, Padhi S. Colon targeted drug delivery system an approach for treating colonic ailments. J Crit Rev 2015;2:12-8.
Song L, Bai L, Xu X, He J, Pan S. Inclusion complexation, encapsulation interaction and inclusion number in cyclodextrin chemistry. Coord Chem Rev 2009;253:1276-84.
Yatsu F, Koester L, Lula I, Passos J, Sinisterra R, Bassani V. Multiple complexations of cyclodextrin with soy isoflavones present in an enriched fraction. Carbohydr Polym 2013; 98:726-35.
Loftsson T, Brewster M. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilisation. J Pharm Sci 1996;85:1017-25.
Rajewski RA, Stella VJ. Pharmaceutical applications of cyclodextrins 2. In vivo drug delivery. J Pharm Sci 1996;85:1142–69.
ME Dalmora, SL Dalmora, G Oliveira. Inclusion complex of piroxicam and B-cyclodextrin and incorporation in the cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int J Pharm 2001;222:45–55.
T Loftsson, AM Sigurdardottir, H Olafsson. Improved acitretin delivery through hairless mouse skin by cyclodextrin complexation. Int J Pharm 1995;115:255–8.
Riekes M, Tagliari M, Granada A, Kuminek G, Silva M, Stulzer H. Enhanced solubility and dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods. Mater Sci Eng C 2010;30:1008-13.
Rossel C, Sepúlveda Carreño J, RodrÃguez-Baeza M, Alderete J. Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in the solid phase. QuÃmica Nova 2000;23:749-52.
Zerrouk N, Corti G, Ancillotti S, Maestrelli F, Cirri M, Mura P. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm 2006;62:241-6.
Ventura C, Tommasini S, Falcone A. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. Int J Pharm 2006;314:37-45.
Archontaki H, Vertzoni M, Athanassiou-Malaki M. Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl-cyclodextrins. J Pharm Biomed Anal 2002;28:761-9.
Lu Z, Cheng B, Hu Y, Zhang Y, Zou G. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity. Food Chem 2009;113:17-20.
Ali MF. Topical delivery and photodynamic evaluation of a multivesicular liposomal Rose Bengal. Lasers Med Sci 2011; 26:267–75.
Kim ED, El-rashidy R, McVary KT. Papaverine topical gel for the treatment of erectile dysfunction. J Urol 1995;153:361–5.
Szejtli J. Introduction and a general overview of cyclodextrin chemistry. Chem Rev 1998;98:1743-54.
Hapiot F, Tilloy S, Monflier E. Cyclodextrins as supramolecular hosts for organometallic complexes. Chem Rev 2006;106:767-81.
Harata K. X-ray structure of hexakis (2, 3, 6-tri-O-acetyl)-. ALPHA.-cyclodextrin. Chem Lett 1998;7:589-90.
Li S Purdy W. Cyclodextrins and their applications in analytical chemistry. Chem Rev 1992;92:1457-70.
Mohanty J, Bhasikuttan A, Nau W, Pal H. Host−guest complexation of neutral red with macrocyclic host molecules: contrasting p K shifts and binding affinities for cucurbit [7] uril and β-cyclodextrin. J Phys Chem B 2006;110:5132-8.
Rekharsky M, Inoue Y. Complexation thermodynamics of cyclodextrins. Chem Rev 1998;98:1875-918.
Al-Omari M, Zughul M, Davies J, Badwan A. Thermodynamic enthalpy–entropy compensation effects observed in the complexation of basic drug substrates with β-cyclodextrin. J Inclusion Phenom Macrocyclic Chem 2007;57:379-84.
SZ Chemate, KPR Chowdary. A factorial study on enhancement of solubility and dissolution rate of lornoxicam employing β-cyclodextrin and surfactants. Int J Pharm Res Dev 2012;4:350-6.
Echezarreta-López M, Torres-Labandeira J, Castiñeiras-Seijo L, Santana-PenıÌn L, Vila-Jato J. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 2000;9:381-6.
Prabhakaran R, Janakiraman K, Harindran J. Formulation and evaluation of taste masked oral suspension of cefuroxime axetil using hydroxypropyl-beta-cyclodextrin. Asian J Pharm Clin Res 2016;9:90-2.
Nagase Y, Hirata M, Wada K, Arima H, Hirayama F, Irie T, et al. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin. Int J Pharm 2001;229:163-72.
Fan Z, Diao C, Yu M, Jing Z, Chen X, Deng Q. An investigation of the inclusion complex of β-Cyclodextrin with 8-nitro-quinoline in the solid state. Supramol Chem 2006;18:7-11.
Harata K, Song L, Morii H. X-ray structure of a 1:2 complex of hexakis (3-O-acetyl-2,6-di-O-methyl)-α-cyclodextrin with butyl acetate. J Supramol Chem 2000;11:217-24.
VreÄer F, Vrbinc M, Meden A. Characterization of piroxicam crystal modifications. Int J Pharm 2003;256:3-15.
Koester L. Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm 2003;55:85-91.
Jug, M, Bećirević-Laćan M. Influence of hydroxypropyl-β-cyclodextrincomplexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 2004;21:251-60.
Redenti E, Peveri T, Zanol M, Ventura P, Gnappi G, Montenero A. A study on the differentiation between amorphous piroxicam: β-cyclodextrin complex and a mixture of the two amorphous components. Int J Pharm 1996;129:289-94.
Lindner K, Saenger W. Crystal and molecular structures of cyclomaltoheptaose inclusion complexes with HI and with methanol. Carbohydr Res 1982;107:7-16.
Liu Y, Chen G, Zhang H, Song H, Ding F. Interaction between β-cyclodextrin and 1,10-phenanthroline: uncommon 2:3 inclusion complex in the solid state. Carbohydr Res 2004;339:1649-54.
Markovich R, Anderson Evans C, Coscolluela C, Zibas S, Rosen J. Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation. J Pharm Biomed Anal 1997;16:661-73.
Ford JL. The current status of solid dispersions. Pharm Acta Helv 1986;61:69–88.
Stulzer H, Tagliari M, Parize A, Silva M, Laranjeira M. Evaluation of cross-linked chitosan microparticles containing acyclovir obtained by spray-drying. Mater Sci Eng C 2009;29:387-92.
Stezowski J, Jogun K, Eckle E, Bartels K. Dimeric β-cyclodextrin complexes may mimic membrane diffusion transport. Nature 1978;274:617-9.
Ahmed S, Naggi A, Guerrini M, Focher B. Inclusion complexes of bropirimine with β-cyclodextrin in solution and in the solid state. Int J Pharm 1991;77:247-54.
Silverstein R, Webster F, Kiemle D. Spectrometric identification of organic compounds. New York: Wiley; 2004.
Published
How to Cite
Issue
Section
